158 related articles for article (PubMed ID: 8746269)
1. Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance.
Riva C; Lavieille JP; Reyt E; Brambilla E; Lunardi J; Brambilla C
Eur J Cancer B Oral Oncol; 1995 Nov; 31B(6):384-91. PubMed ID: 8746269
[TBL] [Abstract][Full Text] [Related]
2. Correlated expression of glutathione S-transferase-pi and c-Jun or other oncogene products in human squamous cell carcinomas of the head and neck: relevance to relapse after radiation therapy.
Miura K; Suzuki S; Tanita J; Shinkawa H; Satoh K; Tsuchida S
Jpn J Cancer Res; 1997 Feb; 88(2):143-51. PubMed ID: 9119742
[TBL] [Abstract][Full Text] [Related]
3. Expression of Egr-1 gene and its correlation with the oncogene proteins in non-irradiated and irradiated esophageal squamous cell carcinoma.
Wu MY; Wu XY; Li QS; Zheng RM
Dis Esophagus; 2006; 19(4):267-72. PubMed ID: 16866858
[TBL] [Abstract][Full Text] [Related]
4. [Drug resistance, oncogenes, and anti-oncogenes in epithelial tumors].
Riva-Lavieille C
Bull Cancer; 1994 Dec; 81 Suppl 2():105s-111s. PubMed ID: 7727855
[TBL] [Abstract][Full Text] [Related]
5. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.
Nylander K; Dabelsteen E; Hall PA
J Oral Pathol Med; 2000 Oct; 29(9):413-25. PubMed ID: 11016683
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma.
Field JK; Spandidos DA; Stell PM; Vaughan ED; Evan GI; Moore JP
Oncogene; 1989 Dec; 4(12):1463-8. PubMed ID: 2687767
[TBL] [Abstract][Full Text] [Related]
7. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
8. Patients with high c-MYC-expressing squamous cell carcinomas of the tongue show better survival than those with low- and medium-expressing tumours.
Strindlund K; Troiano G; Sgaramella N; Coates PJ; Gu X; Boldrup L; Califano L; Fahraeus R; Muzio LL; Ardito F; Colella G; Tartaro G; Franco R; Norberg-Spaak L; Saadat M; Nylander K
J Oral Pathol Med; 2017 Nov; 46(10):967-971. PubMed ID: 28393404
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas.
Waitzberg AF; Nonogaki S; Nishimoto IN; Kowalski LP; Miguel RE; Brentani RR; Brentani MM
Cancer Detect Prev; 2004; 28(3):178-86. PubMed ID: 15225897
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
[TBL] [Abstract][Full Text] [Related]
11. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
12. C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix.
Riou G; Barrois M; Lê MG; George M; Le Doussal V; Haie C
Lancet; 1987 Apr; 1(8536):761-3. PubMed ID: 2882179
[TBL] [Abstract][Full Text] [Related]
13. Implications of p53 alterations and anti-p53 antibody response in head and neck squamous cell carcinomas.
Lavieille JP; Righini C; Reyt E; Brambilla C; Riva C
Oral Oncol; 1998 Mar; 34(2):84-92. PubMed ID: 9682769
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
[TBL] [Abstract][Full Text] [Related]
15. Sulfur dioxide and benzo(a)pyrene modulates CYP1A and tumor-related gene expression in rat liver.
Qin G; Meng Z
Environ Toxicol; 2010 Apr; 25(2):169-79. PubMed ID: 19408242
[TBL] [Abstract][Full Text] [Related]
16. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
[TBL] [Abstract][Full Text] [Related]
17. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
Frank DK; Liu TJ; Frederick MJ; Clayman GL
Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
[TBL] [Abstract][Full Text] [Related]
18. Heat-induced growth inhibition and apoptosis in transplanted human head and neck squamous cell carcinomas with different status of p53.
Tamamoto T; Yoshimura H; Takahashi A; Asakawa I; Ota I; Nakagawa H; Ohnishi K; Ohishi H; Ohnishi T
Int J Hyperthermia; 2003; 19(6):590-7. PubMed ID: 14756450
[TBL] [Abstract][Full Text] [Related]
19. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
[TBL] [Abstract][Full Text] [Related]
20. p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.
Pagnano KB; Vassallo J; Lorand-Metze I; Costa FF; Saad ST
Am J Hematol; 2001 Jun; 67(2):84-92. PubMed ID: 11343379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
